Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CF CF Industries	$88.86 -0.6%	$78.08	$67.34 ▼ $98.25	$15.06B	0.94	2.14 million shs	763,194 shs
MCK McKesson	$714.48 -0.6%	$687.71	$464.42 ▼ $731.00	$89.27B	0.53	914,532 shs	241,112 shs
UBS UBS Group	$32.10 +0.4%	$30.45	$25.75 ▼ $35.84	$102.91B	1.15	2.33 million shs	1.08 million shs

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CF CF Industries	+1.63%	+4.62%	+18.90%	+11.37%	+13.69%
MCK McKesson	-0.16%	+5.24%	+5.15%	+18.93%	+29.97%
UBS UBS Group	-0.94%	-2.40%	+15.73%	-4.68%	+5.18%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CF CF Industries	3.9424 of 5 stars	2.1	2.0	2.5	0.0	3.6	1.7	3.1
MCK McKesson	4.3655 of 5 stars	2.4	3.0	3.3	3.0	3.6	2.5	1.3
UBS UBS Group	3.6256 of 5 stars	0.0	5.0	2.5	0.0	2.6	0.0	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CF CF Industries	2.27	Hold	$90.21	1.53% Upside
MCK McKesson	2.87	Moderate Buy	$686.69	-3.89% Downside
UBS UBS Group	2.57	Moderate Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest CF, MCK, and UBS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/14/2025	CF CF Industries	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$87.00 ➝ $91.00
5/12/2025	UBS UBS Group	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/12/2025	CF CF Industries	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$96.00 ➝ $98.00
5/9/2025	MCK McKesson	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$755.00 ➝ $800.00
5/8/2025	CF CF Industries	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$79.00 ➝ $82.00
5/6/2025	UBS UBS Group	DZ Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
4/29/2025	MCK McKesson	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$708.00 ➝ $805.00
4/22/2025	CF CF Industries	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$95.00 ➝ $87.00
4/22/2025	CF CF Industries	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
4/17/2025	UBS UBS Group	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Moderate Sell ➝ Hold
4/16/2025	CF CF Industries	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$90.00 ➝ $79.00

(Data available from 5/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CF CF Industries	$6.13B	2.46	$13.63 per share	6.52	$43.63 per share	2.04
MCK McKesson	$359.05B	0.25	$38.87 per share	18.38	($21.58) per share	-33.11
UBS UBS Group	$44.79B	2.30	$2.65 per share	12.10	$26.69 per share	1.20

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CF CF Industries	$1.53B	$7.59	13.12	15.16	0.37	20.52%	15.50%	8.87%	8/6/2025 (Estimated)
MCK McKesson	$3.00B	$25.83	32.67	19.50	1.29	0.82%	-181.26%	5.34%	8/6/2025 (Estimated)
UBS UBS Group	$5.09B	$1.51	21.11	10.63	N/A	6.93%	5.93%	0.32%	N/A

Latest CF, MCK, and UBS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2025	Q4 2025	MCK McKesson	$9.83	$10.12	+$0.29	$10.01	$94.00 billion	$90.82 billion
5/7/2025	Q1 2025	CF CF Industries	$1.47	$1.85	+$0.38	$1.85	$1.53 billion	$1.66 billion
4/30/2025	Q1 2025 (Fixed Income)	UBS UBS Group	$0.42	$0.51	+$0.09	$0.51	$10.19 billion	$11.90 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CF CF Industries	$2.00	2.25%	+18.56%	26.35%	3 Years
MCK McKesson	$2.84	0.40%	+14.33%	10.99%	17 Years
UBS UBS Group	$0.22	0.69%	+23.68%	14.57%	5 Years

Latest CF, MCK, and UBS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/1/2025	MCK McKesson	quarterly	$0.71	0.4%	6/2/2025	6/2/2025	7/1/2025
4/29/2025	CF CF Industries	quarterly	$0.50	2.51%	5/15/2025	5/15/2025	5/30/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CF CF Industries	0.39	3.08	2.52
MCK McKesson	N/A	0.88	0.48
UBS UBS Group	3.76	1.06	1.05

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CF CF Industries	93.06%
MCK McKesson	85.07%
UBS UBS Group	N/A

Insider Ownership

Company	Insider Ownership
CF CF Industries	0.42%
MCK McKesson	0.11%
UBS UBS Group	1.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CF CF Industries	2,700	169.54 million	173.29 million	Optionable
MCK McKesson	75,000	125.11 million	125.19 million	Optionable
UBS UBS Group	72,600	3.21 billion	3.17 billion	Optionable

CF, MCK, and UBS Headlines

Recent News About These Companies

Wall Street bets on pair trade that favours consumer over housing

May 22 at 11:18 AM | moneyweb.co.za

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Stake in UBS Group AG (NYSE:UBS)

May 22 at 7:18 AM | marketbeat.com

UBS sets USD/CAD target at 1.34 for June 2026 post-election

May 22 at 5:59 AM | investing.com

UBS Group AG (NYSE:UBS) Given Average Recommendation of "Moderate Buy" by Analysts

May 22 at 5:11 AM | americanbankingnews.com

UBS Group AG Ceases Substantial Holding in Gold Road Resources

May 22 at 2:53 AM | tipranks.com

UBS Upgrades Delta Air Lines (DAL) to Buy, Lifts PT

May 22 at 2:33 AM | finance.yahoo.com

Ultra rich wanted more China exposure before trade war: survey

May 22 at 1:16 AM | businesstimes.com.sg

UBS rejigs wealth management unit

May 22 at 1:16 AM | msn.com

Ultra Rich Wanted More China Exposure Before Trade War, UBS Says

May 22 at 1:16 AM | bloomberg.com

'As of today, we are a Swiss organization', says UBS' Iqbal Khan

May 21 at 11:04 PM | youtube.com

UBS Group's outlook revised to positive by Fitch; IDR affirmed at A

May 21 at 8:15 PM | msn.com

New Analyst Forecast: $DHR Given 'Buy' Rating

May 21 at 7:05 PM | quiverquant.com

UBS Keeps Buy Rating on MSCI with $655 Price Target

May 21 at 6:42 PM | insidermonkey.com

UBS Reduces Stake in Gentrack Group Ltd

May 21 at 5:55 PM | tipranks.com

SA analyst downgrades: NVDA, AMD, TPR, HUBS, CPB

May 21 at 3:41 PM | seekingalpha.com

$TZUP stock is up 15% today. Here's what we see in our data.

May 21 at 11:56 AM | quiverquant.com

Strategic Global Advisors LLC Purchases New Shares in UBS Group AG (NYSE:UBS)

May 21 at 6:07 AM | marketbeat.com

Family offices keep ‘strong bias to the U.S.’ amid market turmoil, UBS survey finds

May 21 at 3:06 AM | fortune.com

UBS Upgrades Archer Daniels (ADM) Stock to Buy, Lifts PT

May 21 at 2:42 AM | finance.yahoo.com

UBS Group AG Acquires Substantial Holding in Gentrack Group

May 20 at 11:17 PM | tipranks.com

CXAPP Earnings Results: $CXAI Reports Quarterly Earnings

May 20 at 7:06 PM | quiverquant.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CF, MCK, and UBS Company Descriptions

CF Industries NYSE:CF

$88.86 -0.49 (-0.55%)

As of 01:17 PM Eastern

CF Industries Holdings, Inc., together with its subsidiaries, engages in the manufacture and sale of hydrogen and nitrogen products for energy, fertilizer, emissions abatement, and other industrial activities in North America, Europe, and internationally. It operates through Ammonia, Granular Urea, UAN, AN, and Other segments. The company's principal products include anhydrous ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate products. It also offers diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia products. The company primarily serves cooperatives, independent fertilizer distributors, traders, wholesalers, and industrial users. CF Industries Holdings, Inc. was founded in 1946 and is headquartered in Northbrook, Illinois.

McKesson NYSE:MCK

$714.48 -4.25 (-0.59%)

As of 01:17 PM Eastern

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

UBS Group NYSE:UBS

$32.10 +0.13 (+0.39%)

As of 01:16 PM Eastern

UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through five divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-core and Legacy. The company offers investment advice, estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions. It also provides personal banking products and services, such as deposits, credit and debit cards, and online and mobile banking, as well as lending, investments, retirement, and wealth management services; and corporate and institutional solutions, including equity and debt capital markets, syndicated and structured credit, private placements, leasing, traditional financing, and transaction banking solutions for payment and cash management services, trade and export finance, and global custody solutions. In addition, the company offers equities, fixed income, hedge funds, real estate and private markets, indexed and alternative beta strategies, asset allocation and currency investment strategies, customized multi-asset solutions, advisory and fiduciary services, and multi-manager hedge fund solutions and advisory services. Further, it advises clients on strategic business opportunities and helps them raise capital to fund their activities; enables its clients to buy, sell, and finance securities on capital markets and to manage their risks and liquidity; distributes, trades in, finances, and clears cash equities and equity-linked products; structures, originates, and distributes new equity and equity-linked issues; and originates, distributes, manages risk, and provides liquidity in foreign exchange, rates, credit and precious metals. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is headquartered in Zurich, Switzerland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time